Rocuronium bromide NEW

Rocuronium bromide is a novel non-depolarizing neuromuscular blocking agent and a derivative of vecuronium. It is currently the fastest-acting intermediate-duration non-depolarizing neuromuscular blocker among the aminosteroid category, with an onset time only surpassed by succinylcholine, yet without the associated adverse reactions such as fasciculations, malignant hyperthermia, hyperkalemia, and increased intraocular pressure. Rocuronium offers benefits such as minimal accumulation and no histamine release. It features a rapid onset, intermediate duration, swift recovery, no histamine release, and does not block autonomic ganglia.